BCRX vs DEO · rev $374.7M vs P/E 16, $55.86B cap
BioCryst Pharmaceuticals Inc (BCRX) versus Diageo PLC ADR (DEO) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
DEO does not have a complete income-statement cache yet.
BCRX currently screens at market cap $1.83B. DEO currently screens at market cap $55.86B and trailing P/E 15.6.
Not investment advice. Open the BCRX and DEO stock pages for the full models.
Not investment advice.